40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.58%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-40.04%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-37.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-37.43%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
46.26%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
49.37%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
49.94%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-16.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-16.23%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
52.63%
Dividend growth above 1.5x MTDR's 0.08%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
1.12%
Positive OCF growth while MTDR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
25.48%
Positive FCF growth while MTDR is negative. John Neff would see a strong competitive edge in net cash generation.
139.84%
10Y revenue/share CAGR under 50% of MTDR's 690.14%. Michael Burry would suspect a lasting competitive disadvantage.
139.84%
5Y revenue/share CAGR under 50% of MTDR's 1272.50%. Michael Burry would suspect a significant competitive gap or product weakness.
152.42%
Positive 3Y CAGR while MTDR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
467.41%
10Y OCF/share CAGR under 50% of MTDR's 1566.28%. Michael Burry would worry about a persistent underperformance in cash creation.
467.41%
5Y OCF/share CAGR 1.25-1.5x MTDR's 362.73%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
195.65%
Positive 3Y OCF/share CAGR while MTDR is negative. John Neff might see a big short-term edge in operational efficiency.
697.91%
Net income/share CAGR above 1.5x MTDR's 163.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
697.91%
5Y net income/share CAGR above 1.5x MTDR's 139.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
332.86%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
135.21%
Below 50% of MTDR's 274.37%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
135.21%
5Y equity/share CAGR at 50-75% of MTDR's 204.54%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
149.39%
3Y equity/share CAGR 1.25-1.5x MTDR's 101.40%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
146.65%
Dividend/share CAGR of 146.65% while MTDR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
146.65%
Dividend/share CAGR of 146.65% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
173.31%
Below 50% of MTDR's 529.33%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-3.17%
Firm’s AR is declining while MTDR shows 2.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
21.05%
Inventory growth well above MTDR's 23.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.76%
Asset growth above 1.5x MTDR's 1.79%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
29.82%
BV/share growth above 1.5x MTDR's 2.09%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.07%
We’re deleveraging while MTDR stands at 0.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-89.96%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.